Tropical splenomegalies: Hyperreactive malarial splenomegaly and tropical splenic lymphoma with villous lymphocytes;Splénomégalies tropicales: Splénomégalie palustre hyperréactive et lymphome splénique tropical à lymphocytes villeux

Hematologie

Volumn 11, Issue 4, 2005, Pages 259-263

  Dascalescu, Cristina Mihaela ^a,b   Najman, Albert ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b Edouard Rist Medical Center   (France)

Author keywords

bcl 2 jh gene rearrangement; FR3 JH gene rearrangement; Hyperreactive malarial splenomegaly; Splenic lymphoma with villous lymphocytes

Indexed keywords

IMMUNOGLOBULIN M;

AFRICA; DIFFERENTIAL DIAGNOSIS; ENDEMIC DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTE; LYMPHOMA; MALARIA; PANCYTOPENIA; SHORT SURVEY; SPLENOMEGALY; TROPICAL DISEASE;

EID: 26044449995     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (20)

1. Bates I, Bedu-Addo G. Review of diagnostic criteria of hyperreactive malarial splenomegaly. Lancet 1997; 349: 1178.
2. Bates I, Bedu-Addo G, Bevan DH, Rutherford TR. Use of immunoglobulin gene rearrangements to show clonal lymphoproliferation in hyper-reactive malarial splenomegaly. Lancet 1991; 337: 505-7.
3. Wallace S, Bedu-Addo G, Rutherford TR, Bates I. Serological similarities between hyperreactive malarial splenomegaly and splenic lymphoma in West Africa. Trans R Soc Trop Med Hyg 1998; 92: 463-7.
4. Bates I, Bedu-Addo G, Rutherford TR, Bevan DH. Splenic lymphoma with villous lymphocytes in tropical West Africa. Lancet 1992; 340: 575-7.
5. Jimmy EO, Bedu-Addo G, Bates I, Bevan D, Rutherford TR. Immunoglobulin gene polymerase chain reaction to distinguish hyperreactive malarial splenomegaly from "African" chronic lymphocytic leukaemia and splenic lymphoma. Trans R Soc Trop Med Hyg 1996; 90: 37-9.
6. Bates I, Bedu-Addo G, Rutherford TR, Bevan DH. Circulating villous lymphocytes - a link between hyper-reactive malarial splenomegaly and splenic lymphoma. Trans R Soc Trop Med Hyg 1997; 91: 171-4.
7. Bates I, Bedu-Addo G. Chronic malaria and splenic lymphoma: clues to understanding lymphoma evolution. Leukemia 1997; 11: 2162-7.
8. H somatic mutations in splenic marginal zone lymphoma. Blood 2002; 99: 1299-304.
9. H gene sequences from a novel tropical splenic lymphoma reveal a naive B cell as the cell of origin. Br J Haematol 1999; 107: 114-20.
10. Bates I, Bedu-Abbo G, Jarrett RF, et al. B-lymphotropic virusis in a novel tropical splenic lymphoma. Br J Haematol 2001; 112: 161-6.
11. Dascalescu CM, Bonte H, Agha Mir I, et al. Bcl-2 and immunoglobulin gene rearrangements in patients with malaria related chronic splenomegaly. Leuk Lymphoma 2004; 45: 2093-7.
12. Franco V, Florena AM, Campesi G. Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma. Histopathology 1996; 29: 571-5.
13. Labouyrie F, Marit G, Vial J, et al. Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: a helpful immunonistologic feature. Mod Pathol 1997; 10: 1015-20.
14. Oscier D, Matutes E, Gardiner A, Glyde S, Mould S, Brito-Babapulle V. Cytogenetic studies in splenic lymphoma with villous lymphocytes. Br J Haematol 1993; 85: 486-91.
15. Rauzy O, Galoin S, Chale JJ, et al. Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases. Mol Pathol 1998; 51: 333-8.
16. Kitay-Cohen Y, Amiel A, Hilzenrat N, et al. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 2000; 96: 2910-2.
17. Zuckerman E, Zuckerman T, Sahar D, et al. Bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C with virus infection. Br J Haematol 2001; 112: 364-9.
18. Betticher DC, Nicole A, Pugin P, Regamey C. The hyperreactive malaria syndrome in an European: Has the treatment a modulatory effect on the immune system? J Infect Dis 1990; 161: 157-9.
19. Goldman FD, Gilman AL, Hollenback C, Kato RM, Premack BA, Rawlings DJ. Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties. Blood 2000; 95: 3460-86.
20. Lagneaux L, Delforge A, Carlier S, Massy M, Bernier M, Bron D. Early induction of apoptosis in B-chronic lymphocytic leukaemia cells by hydroxychloroquine: activation or caspase-3 and no protection by survival factors. Br J Haematol 2001; 112: 344-52.